The spraying exercise is part of a five-year USAID-funded project in several districts of Eastern Uganda. It will involve the use of Fludora-Fusion, a new vector control solution that was recently prequalified by the World Health Organisation, after being tested against more than a dozen of resistant mosquito strains in Sub-Saharan Africa. The exercise will last 24 days, effective April 26.
The recommendation was made after a review of 63 cases of reported blood clots that developed moments after receiving the vaccine from several European countries. The majority of the cases were among females below 60 years of age, some aged 24, who developed clots after receiving their first vaccine jab.